| HOME >> MEDICINE >> TECHNOLOGY |
$15,175,304$11,854,127Accounts receivable, net
2,577,1342,704,434Inventories
869,554698,742Other
465,568363,639Total current assets
19,087,56015,620,942Property, plant, and equipment, net
1,087,1821,171,979Intangible assets, net
519,030945,880Long-term investments
240,0004,429,140Deferred tax assets
117,456122,872Total assets
$21,051,228$22,290,813Liabilities and Shareholders' EquityCurrent liabilities:Accounts payable
$614,919$593,585Current portion – deferred rent
35,00035,000Income tax payable
6,48017,892Accrued liabilities:Compensation
1,501,9951,576,147Other
407,074316,995Total current liabilities
2,565,4682,539,619Deferred rent – less current portion
23,66942,043Accrued pension liability
424,481474,396Total liabilities
3,013,6183,056,058Total shareholders' equity
18,037,61019,234,755Total liabilities and shareholders' equity
$21,051,228$22,290,813 UROPLASTY, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)Six Months EndedSeptember 3020122011Cash flows from operating activities:Net loss
$(1,658,881)$(2,609,794)Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization
576,665552,275 Loss on disposal of equipment
2,7976,475 Amortization of premium on marketable securities
26,71617,039 Share-based consulting expense
1,6232,787 Share-based compensation expense
353,060288,754 Deferred income tax expense (benefit)
2,860(3,040) Deferred rent credit
(18,374)(17,614) Changes in operating assets and liabilities:Accounts receivable, net
100,537(196,435)I
'/>"/>
| SOURCE Uroplasty, Inc. Copyright©2012 PR Newswire. All rights reserved |